Investigation of Pediatric Brucellosis

Background and Aim: Brucellosis (also known as undulant fever, Mediterranean fever, or Malta fever) is a zoonotic infection transmitted to humans from infected animals (sheep, cattle, goats, pigs, camels, or other animals) by ingestion of food products (such as unpasteurized dairy products) or by contact with tissue or fluids.  This disease occurs on average in 11 to 56 percent of children in endemic regions. Despite being long recognized and controllable, the disease still causes substantial morbidity, affecting especially the young population. The objective of this research was to examine the clinical, laboratory results of childhood brucellosis and brucellosis epidemiological features in patients up to 15 years in the province in Pol-e Dokhtar city, Iran. Methods The diagnosis of brucellosis was established on the basis of clinical features, and positive results from Serologic evaluation included Wright test and the 2-mercaptoethanol (2ME) test. This information includes medical records of brucellosis patients in the years 2016 to 2019. SPSS software (version 22.0) was used for the data analysis. Results: Among the patients infected with Brucella, 19 males (70.37%) and 8 females (29.63%) were diagnosed and  11 patients (40.74%) were 5-9 years of age, 10 patients (37%) were 10-15 years of age, and 6 patients (22.26%) were < 5 year of age. Also 27 (100%) patients were from rural regions (the total of affected children) that confirmed direct contact with infected animals in all of them was already established. The most frequent seasons of disease occurrence were summer (33.38%) and winter (29.6%). Conclusion: Considering that 100% of the infection of children has been seen in those who lived in the village, it requires regular vaccination of livestock and proper training in the field of disease prevention. *Corresponding Authors: Faranak Rezaei, Email: [email protected]; Iman Pouladi, Email: [email protected] Please cite this article as: Babaei Z, Azizi abi F, Pouladi I, Rezaei F. Investigation of Pediatric Brucellosis in Pol-e Dokhtar city, Iran. Arch Med Lab Sci. 2020;6:1-4 (e14). https://doi.org/10.22037/amls.v6.3054

Designing a novel multi‑epitope vaccine against Ebola virus using reverse vaccinology approach

Ebola virus (EBOV) is a dangerous zoonotic infectious disease. To date, more than 25 EBOV outbreaks have been documented, the majority of which have occurred in Central Africa. The rVSVG-ZEBOV-GP vaccine (ERVEBO), a live attenuated vaccine, has been approved by the US Food and Drug Administration (FDA) to combat EBOV. Because of the several drawbacks of live attenuated vaccines, multi-epitope vaccines probably appear to be safer than live attenuated vaccines. In this work, we employed immunoinformatics tools to design a multi-epitope vaccine against EBOV. We collected sequences of VP35, VP24, VP30, VP40, GP, and NP proteins from the NCBI database. T-cell and linear B-cell epitopes from target proteins were identified and tested for antigenicity, toxicity, allergenicity, and conservancy. The selected epitopes were then linked together in the vaccine's primary structure using appropriate linkers, and the 50S ribosomal L7/L12 (Locus RL7 MYCTU) sequence was added as an adjuvant to the vaccine construct's N-terminal. The physicochemical, antigenicity, and allergenicity parameters of the vaccine were all found to be satisfactory. The 3D model of the vaccine was predicted, refined, and validated. The vaccine construct had a stable and strong interaction with toll-like receptor 4 (TLR4) based on molecular docking and molecular dynamic simulation (MD) analysis. The results of codon optimization and in silico cloning revealed that the proposed vaccine was highly expressed in Escherichia coli (E. coli). The findings of this study are promising; however, experimental validations should be carried out to confirm these findings

Dras·h Alshkhsyh and Alzmn element as per Rvayh research and Waleed Ibrahim Jabra M. Ljbra

تشمل آرا جبرا النقدیه علی عناصر الروایه و یما ان روایه البحث عن ولید مسعود نموذج من روایاته التی تمثاز بقوه عناصرها، هذا جاء البحث لیلقی الضوء علی آراء جبرا ابراهیم جبرا فی عنصری الشخصیه و الزمن معتمدا علی المنهج الوصفی التحلیلی المتعرف علی ابداعه النقدی و مدی تطبیق آرائه عن الشخصیه و الزمن فی هذه الروایه

Molecular Detection and Evaluation of ML Resistance M. Pneumoniae Associated with Mutation in 23S RNA Gene among Iranian Patients with Respiratory Infections

Background: Mycoplasma pneumoniae is a common cause of community-acquired pneumonia. The global increased resistance of M. pneumoniae strains to macrolide (ML) has become a worrisome health problem. The widespread use of these medications has led to increased rate of reported ML-resistant M. pneumoniae (MRMP) throughout the world. This study was aimed to evaluate the resistance of M. pneumoniae against erythromycin due to mutations in the 23S rRNA gene of patients with respiratory infections in Iran. Methods: In this study, 100 samples of throat swab from a patient with respiratory problems were collected. After the cultured of all samples in M. pneumonia-specific PPLO medium, PCR technique was performed with specific primers. Afterwards, the broth micro-dilution MIC assay was employed. Finally, the PCR product of the 23S rRNA gene was sequenced to detect mutations of domain V in 23S rRNA gene of MRMP. Results: It was found that 17 cases (17) were positive for mycoplasma genus and six cases (6) positive for M. pneumoniae species. Also, analysis of the sequence of 23S rRNA gene, revealed that one of the samples had mutations at positions A2431G and G2491A. All positive samples M. pneumoniae with 23S rRNA gene were sensitive to erythromycin. Conclusion: These use of these antibiotics should be limited to prevent the emergence of MRMP in Iran

Molecular Detection and Evaluation of ML- Resistance M. Pneumoniae Associated with Mutation in 23S RNA Gene among Iranian Patients with Respiratory Infections

Background: Mycoplasma pneumoniae is a common cause of community-acquired pneumonia. The global increased resistance of M. pneumoniae strains to macrolide (ML) has become a worrisome health problem. The widespread use of these medications has led to increased rate of reported ML-resistant M. pneumoniae (MRMP) throughout the world. This study was aimed to evaluate the resistance of M. pneumoniae against erythromycin due to mutations in the 23S rRNA gene of patients with respiratory infections in Iran. Methods: In this study, 100 samples of throat swab from a patient with respiratory problems were collected. After the cultured of all samples in M. pneumonia-specific PPLO medium, PCR technique was performed with specific primers. Afterwards, the broth micro-dilution MIC assay was employed. Finally, the PCR product of the 23S rRNA gene was sequenced to detect mutations of domain V in 23S rRNA gene of MRMP. Results: It was found that 17 cases (17) were positive for mycoplasma genus and six cases (6) positive for M. pneumoniae species. Also, analysis of the sequence of 23S rRNA gene, revealed that one of the samples had mutations at positions A2431G and G2491A. All positive samples M. pneumoniae with 23S rRNA gene were sensitive to erythromycin. Conclusions: These use of these antibiotics should be limited to prevent the emergence of MRMP in Iran